Renée Galá Joins Dexcom Board of Directors
Slice of Healthcare Team
Mar 14, 2025
Key Highlights
- Renée Galá appointed to Dexcom’s Board of Directors, effective March 6, 2025.
- Brings extensive financial, strategic, and operational leadership experience in the life sciences sector.
- Currently serves as President & COO at Jazz Pharmaceuticals, overseeing global business operations.
- Strong track record in financial leadership, international expansion, and business development at high-growth companies.
Source: Business Wire
Notable Quote
“ We are excited to announce Renée’s appointment to the Dexcom Board today and benefit from her insights. Renée’s extensive experience guiding global finance and global operations including commercial and R&D to drive growth and create shareholder value provides an excellent fit at this key point in Dexcom’s journey. ”
Kevin Sayer, Chairman, President & CEO at Dexcom
Why This Matters
- “We are excited to announce Renée’s appointment to the Dexcom Board today and benefit from her insights. Renée’s extensive experience guiding global finance and global operations including commercial and R&D to drive growth and create shareholder value provides an excellent fit at this key point in Dexcom’s journey.” – Kevin Sayer, Chairman, President & CEO at Dexcom
